Correlation Engine 2.0
Clear Search sequence regions

  • antioxid (1)
  • cellular processes (1)
  • d (10)
  • drug target (1)
  • dyslipidemia (1)
  • humans (1)
  • insulin (3)
  • isoforms (1)
  • lipid (1)
  • liver disease (1)
  • redox (1)
  • regulates (1)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    Significance: Cardiometabolic disorders (CMD) are composed of a plethora of metabolic dysfunctions such as dyslipidemia, nonalcoholic fatty liver disease, insulin resistance, and hypertension. The development of these disorders is highly linked to inflammation and oxidative stress (OxS), two metabolic states closely related to physiological and pathological conditions. Given the drastically rising CMD prevalence, the discovery of new therapeutic targets/novel nutritional approaches is of utmost importance. Recent Advances: The tremendous progress in methods/technologies and animal modeling has allowed the clarification of phospholipase D (PLD) critical roles in multiple cellular processes, whether directly or indirectly via phosphatidic acid, the lipid product mediating signaling functions. In view of its multiple features and implications in various diseases, PLD has emerged as a drug target. Critical Issues: Although insulin stimulates PLD activity and, in turn, PLD regulates insulin signaling, the impact of the two important PLD isoforms on the metabolic syndrome components remains vague. Therefore, after outlining PLD1/PLD2 characteristics and functions, their role in inflammation, OxS, and CMD has been analyzed and critically reported in the present exhaustive review. The influence of functional foods and nutrients in the regulation of PLD has also been examined. Future Directions: Available evidence supports the implication of PLD in CMD, but only few studies emphasize its mechanisms of action and specific regulation by nutraceutical compounds. Therefore, additional investigations are first needed to clarify the functional role of nutraceutics and, second, to elucidate whether targeting PLDs with food compounds represents an appropriate therapeutic strategy to treat CMD. Antioxid. Redox Signal. 34, 252-278.


    Nickolas Auclair, Alain T Sané, Edgard Delvin, Schohraya Spahis, Emile Levy. Phospholipase D as a Potential Modulator of Metabolic Syndrome: Impact of Functional Foods. Antioxidants & redox signaling. 2021 Jan 20;34(3):252-278

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32586106

    View Full Text